Use of Disposable Stethoscope Covers for Reduction of Stethoscope MRSA Contamination

NCT ID: NCT03601741

Last Updated: 2019-09-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-08

Study Completion Date

2019-04-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective pilot study using a randomized, controlled, single blinded, crossover trial design, evaluating the effect of daily antimicrobial stethoscope diaphragm covers versus uncovered stethoscope. Stethoscopes will be cleaned Sani-cloth germicidal disposable wipes which are effective against MRSA. Each participant will then be randomly assigned to 7 days in either the intervention or the control arm. At the end of the 7 days participants stethoscopes will be cleaned again. This will be followed by another 7 days in the arm that they are not in during the first 7 days.

The primary endpoint is MRSA colony count from stethoscope diaphragms cultures at 7 days, focusing on the difference between the intervention and the control periods. The secondary endpoint is the rate of hospital acquired MRSA infection in patients treated by residents during each period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

MRSA

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Antimicrobial Stethoscope Diaphragm Covers

Group Type ACTIVE_COMPARATOR

Daily Antimicrobial Stethoscope Diaphragm Cover

Intervention Type OTHER

Patients will receive package with instructions to use stethoscope cover, and are then instructed to switch in 7 days

Uncovered Stethoscopes

Intervention Type OTHER

Patients receive instruction to begin with no covers, and are then instructed to switch in 7 days

Uncovered Stethoscopes

Group Type ACTIVE_COMPARATOR

Daily Antimicrobial Stethoscope Diaphragm Cover

Intervention Type OTHER

Patients will receive package with instructions to use stethoscope cover, and are then instructed to switch in 7 days

Uncovered Stethoscopes

Intervention Type OTHER

Patients receive instruction to begin with no covers, and are then instructed to switch in 7 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Daily Antimicrobial Stethoscope Diaphragm Cover

Patients will receive package with instructions to use stethoscope cover, and are then instructed to switch in 7 days

Intervention Type OTHER

Uncovered Stethoscopes

Patients receive instruction to begin with no covers, and are then instructed to switch in 7 days

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Internal Medicine Residents

Exclusion Criteria

* NA
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NYU Langone Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marwa Moussa, MD

Role: PRINCIPAL_INVESTIGATOR

NYU Langone Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

New York University School of Medicine

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-01633

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bacterial Contamination of Workwear
NCT01192841 COMPLETED NA